fura-2-am has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arispe, N; Diaz, J; Durell, SR; Guy, HR; Shafrir, Y | 1 |
| Akatsu, H; Baranyi, L; Farkas, I; Fukuda, A; Okada, H; Okada, N; Takahashi, M; Tateyama, H; Yamamoto, N; Yamamoto, T | 1 |
| Janka, Z; Juhász, A; Kálmán, J; Laskay, G; Palotás, A; Penke, B | 1 |
3 other study(ies) available for fura-2-am and Alzheimer Disease
| Article | Year |
|---|---|
Polyhistidine peptide inhibitor of the Abeta calcium channel potently blocks the Abeta-induced calcium response in cells. Theoretical modeling suggests a cooperative binding process.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Binding Sites; Calcium; Calcium Channel Blockers; Calcium Channels; Fura-2; Histidine; Humans; Models, Biological; PC12 Cells; Peptide Fragments; Rats | 2010 |
Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amino Acid Sequence; Animals; Antigens, CD; Brain Chemistry; Calcium Signaling; Cells, Cultured; Complement C5a; Female; Fluorescent Dyes; Fura-2; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Male; Molecular Sequence Data; Neurons; Rats; Receptor, Anaphylatoxin C5a; Receptors, Complement; Signal Transduction; Tumor Cells, Cultured | 2003 |
Comparative studies on [Ca2+]i-level of fibroblasts from Alzheimer patients and control individuals.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Calcium; Fibroblasts; Fluorescent Dyes; Fura-2; Humans; Intracellular Membranes; Middle Aged; Osmolar Concentration; Reference Values; Skin; Spectrometry, Fluorescence | 2001 |